![Frédéric Dumais](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Dumais
Investor Relations Contact chez
VALEO PHARMA INC.
Profil
Mr. Frédéric Dumais is a Director-Communications & Investor Relations at ChitogenX, Inc., a Director-Communications & Investor Relations at Valeo Pharma, Inc. and a Member at Québec Bar Assoication.
Mr. Dumais was previously employed as a Senior Director-Communications & IR by Liminal BioSciences, Inc., a Vice President-Investor Relations by Akela Pharma, Inc., a Head-Investor Relations by Janssen Pharmaceutica NV, and a Vice President-Investor Relations by LAB International, Inc.
Postes actifs de Frédéric Dumais
| Sociétés | Poste | Début |
|---|---|---|
| VALEO PHARMA INC. | Investor Relations Contact | 01/06/2019 |
| CHITOGENX INC. | Investor Relations Contact | 01/06/2019 |
Québec Bar Assoication
 Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Corporate Officer/Principal | - |
Anciens postes connus de Frédéric Dumais
| Sociétés | Poste | Fin |
|---|---|---|
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Public Communications Contact | 13/07/2007 |
| LIMINAL BIOSCIENCES INC. | Investor Relations Contact | - |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Investor Relations Contact | - |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Public Communications Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical formulations and drugs | Health Technology |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance Provides fund management services | Finance |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
ChitogenX, Inc.
 ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company | Health Technology |
Valeo Pharma, Inc.
 Valeo Pharma, Inc. Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals & hospital specialty products | Distribution Services |
